Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tao Fan, Heather A Bennett, Nancy E Smith, Mihaela Marin & Shuvayu Sankar Sen. (2015) Comparison of infliximab and ustekinumab for the treatment of moderate-to-severe psoriasis: an indirect comparison meta-analysis. Comparative Effectiveness Research 5, pages 1-11.
Read now
Read now
Aikaterini Kyriakou, Aikaterini Patsatsi & Dimitrios Sotiriadis. (2013) Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study. Journal of Dermatological Treatment 24:3, pages 162-168.
Read now
Read now
Arthur Kavanaugh, Alan Menter, Alan Mendelsohn, Yaung-Kaung Shen, Seina Lee & Alice B. Gottlieb. (2010) Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial. Current Medical Research and Opinion 26:10, pages 2385-2392.
Read now
Read now
Articles from other publishers (37)
Emilie Sbidian, Anna Chaimani, Robin Guelimi, Ignacio Garcia-Doval, Camille Hua, Carolyn Hughes, Luigi Naldi, Maria Kinberger, Sivem Afach & Laurence Le Cleach. (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
Robin Guelimi, Sivem Afach, Jean Philippe Régnaux, Thomas Bettuzzi, Guillaume Chaby, Emilie Sbidian, Florian Naudet & Laurence Le Cleach. (2022) Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality. British Journal of Dermatology 187:1, pages 29-41.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2022) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2021) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Crossref
Emily Wright, Najeeda Yasmeen, Kinga Malottki, Laura M. Sawyer, Emma Borg, Carsten Schwenke & Richard B. Warren. (2020) Assessing the Quality and Coherence of Network Meta-Analyses of Biologics in Plaque Psoriasis: What Does All This Evidence Synthesis Tell Us?. Dermatology and Therapy 11:1, pages 181-220.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2020) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi, Olivier Chosidow & Laurence Le Cleach. (2017) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
F.M. Ali, A.C. Cueva, J. Vyas, A.A. Atwan, M.S. Salek, A.Y. Finlay & V. Piguet. (2017) A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis. British Journal of Dermatology 176:3, pages 577-593.
Crossref
Crossref
J.M. Carrascosa, M. Galán, R. de Lucas, A. Pérez-Ferriols, M. Ribera & I. Yanguas. (2016) Expert Recommendations on Treating Psoriasis in Special Circumstances (Part II). Actas Dermo-Sifiliográficas (English Edition) 107:9, pages 712-729.
Crossref
Crossref
J.M. Carrascosa, M. Galán, R. de Lucas, A. Pérez-Ferriols, M. Ribera & I. Yanguas. (2016) Recomendaciones de expertos para el tratamiento de la psoriasis en situaciones especiales (II). Actas Dermo-Sifiliográficas 107:9, pages 712-729.
Crossref
Crossref
J.C. Prinz, L. Puig & G. Girolomoni. (2016) Treatment of psoriasis with etanercept: the typical patient profile. Journal of the European Academy of Dermatology and Venereology 30:7, pages 1092-1099.
Crossref
Crossref
R. Strohal, J. C. Prinz, G. Girolomoni & A. Nast. (2015) A patient‐centred approach to biological treatment decision making for psoriasis: an expert consensus. Journal of the European Academy of Dermatology and Venereology 29:12, pages 2390-2398.
Crossref
Crossref
Christian Kromer, Marthe-Lisa Schaarschmidt, Astrid Schmieder, Raphael Herr, Sergij Goerdt & Wiebke K. Peitsch. (2015) Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment. PLOS ONE 10:6, pages e0129120.
Crossref
Crossref
Emilie Sbidian, Laurence Le Cleach, Ludovic Trinquart, Giao Do, Carolyn Hughes, Luigi Naldi, Ignacio Garcia-Doval, John R Ingram & Olivier Chosidow. (2015) Systemic pharmacological treatments for chronic plaque psoriasis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Pedro M. Machado & Siba P. Raychaudhuri. (2014) Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis. Best Practice & Research Clinical Rheumatology 28:5, pages 711-728.
Crossref
Crossref
L. Puig, J.M. Carrascosa, G. Carretero, P. de la Cueva, R.F. Lafuente-Urrez, I. Belinchón, M. Sánchez-Regaña, M. García-Bustínduy, M. Ribera, M. Alsina, C. Ferrándiz, E. Fonseca, V. García-Patos, E. Herrera, J.L. López-Estebaranz, S.E. Marrón, J.C. Moreno, J. Notario, R. Rivera, C. Rodriguez-Cerdeira, A. Romero, R. Ruiz-Villaverde, R. Taberner & D. Vidal. (2013) Spanish Evidence-Based Guidelines on the Treatment of Psoriasis With Biologic Agents, 2013. Part 1: On Efficacy and Choice of Treatment. Actas Dermo-Sifiliográficas (English Edition) 104:8, pages 694-709.
Crossref
Crossref
L. Puig, J.M. Carrascosa, G. Carretero, P. de la Cueva, R.F. Lafuente-Urrez, I. Belinchón, M. Sánchez-Regaña, M. García-Bustínduy, M. Ribera, M. Alsina, C. Ferrándiz, E. Fonseca, V. García-Patos, E. Herrera, J.L. López Estebaranz, S.E. Marrón, J.C. Moreno, J. Notario, R. Rivera, C. Rodriguez-Cerdeira, A. Romero, R. Ruiz-Villaverde, R. Taberner & D. Vidal. (2013) Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento. Actas Dermo-Sifiliográficas 104:8, pages 694-709.
Crossref
Crossref
L Baccaglini, K Thongprasom, M Carrozzo & M Bigby. (2012) Urban legends series: lichen planus. Oral Diseases 19:2, pages 128-143.
Crossref
Crossref
Cassyano Januário Correr, Inajara Rotta, Thaís de Souza Teles, Rangel Ray Godoy, Bruno Salgado Riveros, Mariana Martins Garcia, Patrícia Rodrigues Gonçalves & Michel Fleith Otuki. (2013) Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: a comprehensive meta-analysis of randomized controlled trials. Cadernos de Saúde Pública 29:suppl 1, pages s17-s31.
Crossref
Crossref
Erica L. Baker, Craig I. Coleman, Kurt M. Reinhart, Olivia J. Phung, Lisa Kugelman, Wendy Chen, C. Michael White, Carla M. Mamolo, Joseph C. Cappelleri & William L. Baker. (2012) Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses. Dermatology and Therapy 2:1.
Crossref
Crossref
Hidemi NAKAGAWA, Brad SCHENKEL, Mai KATO, Takeshi KATO & Atsuyuki IGARASHI. (2012) Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial. The Journal of Dermatology 39:9, pages 761-769.
Crossref
Crossref
E. Altobelli, C. Marziliano, M.C. Fargnoli, R. Petrocelli, M. Maccarone, S. Chimenti & K. Peris. (2012) Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features. Journal of the European Academy of Dermatology and Venereology 26:8, pages 976-982.
Crossref
Crossref
K. Reich, A.D. Burden, J.N. Eaton & N.S. Hawkins. (2012) Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. British Journal of Dermatology 166:1, pages 179-188.
Crossref
Crossref
Gillian M. Bell, Gary Reynolds & John D. Isaacs. (2011) Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?. Nature Reviews Rheumatology 7:9, pages 507-516.
Crossref
Crossref
L. Guenther, C. Han, P. Szapary, B. Schenkel, Y. Poulin, M. Bourcier, J.P. Ortonne & H.L. Sofen. (2011) Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials. Journal of the European Academy of Dermatology and Venereology 25:7, pages 851-857.
Crossref
Crossref
Alexa B. Kimball, Kenneth B. Gordon, Richard G. Langley, Alan Menter, Renee J. Perdok & Joaquin Valdes. (2011) Efficacy and safety of ABT-874, a monoclonal anti–interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial. Journal of the American Academy of Dermatology 64:2, pages 263-274.
Crossref
Crossref
D. Moreno-Ramírez, E. Fonseca, P. Herranz & M. Ara. (2010) Realidad terapéutica de la psoriasis moderada-grave en España. Encuesta de opinión. Actas Dermo-Sifiliográficas 101:10, pages 858-865.
Crossref
Crossref
José Luis Rodríguez Díaz. (2010) Evolución de una psoriasis universal. FMC - Formación Médica Continuada en Atención Primaria 17:2, pages 109-110.
Crossref
Crossref
M. Lebwohl, K. Papp, C. Han, B. Schenkel, N. Yeilding, Y. Wang & G.G. Krueger. (2010) Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. British Journal of Dermatology 162:1, pages 137-146.
Crossref
Crossref
D. Moreno-Ramírez, E. Fonseca, P. Herranz & M. Ara. (2010) Treatment of Moderate-to-Severe Psoriasis in Clinical Practice: A Survey of Spanish Dermatologists. Actas Dermo-Sifiliográficas (English Edition) 101:10, pages 858-865.
Crossref
Crossref
Ulrich Mrowietz & Kristian Reich. (2009) Ten years of infliximab: Its role in dermatology. European Journal of Pharmacology 623, pages S10-S16.
Crossref
Crossref
L. K. Proctor, M. Toal, S. Keating, D. Chitayat, N. Okun, R. C. Windrim, G. C. S. Smith & J. C. P. Kingdom. (2009) Placental size and the prediction of severe early‐onset intrauterine growth restriction in women with low pregnancy‐associated plasma protein‐A. Ultrasound in Obstetrics & Gynecology 34:3, pages 274-282.
Crossref
Crossref
B. C. Brown, R. B. Warren, D. J. C. Grindlay & C. E. M. Griffiths. (2009) What’s new in psoriasis? Analysis of the clinical significance of systematic reviews on psoriasis published in 2007 and 2008. Clinical and Experimental Dermatology 34:6, pages 664-667.
Crossref
Crossref
L. Puig, J.M. Carrascosa, E. Daudén, J.L. Sánchez-Carazo, C. Ferrándiz, M. Sánchez-Regaña, M. García-Bustinduy, X. Bordas, J.C. Moreno, J.M. Hernanz, S. Laguarda & V. García-Patos. (2009) Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos. Actas Dermo-Sifiliográficas 100:5, pages 386-413.
Crossref
Crossref
K. Reich, K. Krüger, R. Mössner & M. Augustin. (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. British Journal of Dermatology 160:5, pages 1040-1047.
Crossref
Crossref
Kristian Reich, Uma Yasothan & Peter Kirkpatrick. (2009) Ustekinumab. Nature Reviews Drug Discovery 8:5, pages 355-356.
Crossref
Crossref
L. Puig, J.M. Carrascosa, E. Daudén, J.L. Sánchez-Carazo, C. Ferrándiz, M. Sánchez-Regaña, M. García-Bustinduy, X. Bordas, J.C. Moreno, J.M. Hernanz, S. Laguarda & V. García-Patos. (2009) Spanish Evidence-Based Guidelines on the Treatment of Moderate to Severe Psoriasis with Biologic Agents. Actas Dermo-Sifiliográficas (English Edition) 100:5, pages 386-413.
Crossref
Crossref